BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1038 related articles for article (PubMed ID: 14592543)

  • 1. The mechanism of action of aspirin.
    Vane JR; Botting RM
    Thromb Res; 2003 Jun; 110(5-6):255-8. PubMed ID: 14592543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COX-1 and COX-3 inhibitors.
    Botting R
    Thromb Res; 2003 Jun; 110(5-6):269-72. PubMed ID: 14592546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-inflammatory drugs in the 21st century.
    Rainsford KD
    Subcell Biochem; 2007; 42():3-27. PubMed ID: 17612044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The fight against rheumatism: from willow bark to COX-1 sparing drugs.
    Vane JR
    J Physiol Pharmacol; 2000 Dec; 51(4 Pt 1):573-86. PubMed ID: 11192932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vane's discovery of the mechanism of action of aspirin changed our understanding of its clinical pharmacology.
    Botting RM
    Pharmacol Rep; 2010; 62(3):518-25. PubMed ID: 20631416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual acting anti-inflammatory drugs: a reappraisal.
    Bertolini A; Ottani A; Sandrini M
    Pharmacol Res; 2001 Dec; 44(6):437-50. PubMed ID: 11735348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of action of aspirin-like drugs.
    Vane JR; Botting RM
    Semin Arthritis Rheum; 1997 Jun; 26(6 Suppl 1):2-10. PubMed ID: 9219313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclooxygenase-2 inhibitors: promise or peril?
    Mengle-Gaw LJ; Schwartz BD
    Mediators Inflamm; 2002 Oct; 11(5):275-86. PubMed ID: 12467519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-inflammatory drugs and their mechanism of action.
    Vane JR; Botting RM
    Inflamm Res; 1998 Oct; 47 Suppl 2():S78-87. PubMed ID: 9831328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the mechanism of action of anti-inflammatory drugs. A paper in honour of John Vane.
    Flower RJ
    Thromb Res; 2003 Jun; 110(5-6):259-63. PubMed ID: 14592544
    [No Abstract]   [Full Text] [Related]  

  • 11. Efficacy, safety and potential clinical roles of the COX-2-specific inhibitors.
    van der Bijl P; van der Bijl P
    Int J Immunopathol Pharmacol; 2003; 16(2 Suppl):17-22. PubMed ID: 14552700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of action of nonsteroidal anti-inflammatory drugs.
    Vane JR; Botting RM
    Am J Med; 1998 Mar; 104(3A):2S-8S; discussion 21S-22S. PubMed ID: 9572314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of cyclooxygenase-2 expression by 4-trifluoromethyl derivatives of salicylate, triflusal, and its deacetylated metabolite, 2-hydroxy-4-trifluoromethylbenzoic acid.
    Fernández de Arriba A; Cavalcanti F; Miralles A; Bayón Y; Alonso A; Merlos M; García-Rafanell J; Forn J
    Mol Pharmacol; 1999 Apr; 55(4):753-60. PubMed ID: 10101034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The role of cyclooxygenase and prostaglandins in the pathogenesis of rheumatoid arthritis].
    Stańczyk J; Kowalski ML
    Pol Merkur Lekarski; 2001 Nov; 11(65):438-43. PubMed ID: 11852819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitors of cyclooxygenases: mechanisms, selectivity and uses.
    Botting RM
    J Physiol Pharmacol; 2006 Nov; 57 Suppl 5():113-24. PubMed ID: 17218763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Control of COX-2 and iNOS gene expressions by aspirin and salicylate.
    Wu KK
    Thromb Res; 2003 Jun; 110(5-6):273-6. PubMed ID: 14592547
    [No Abstract]   [Full Text] [Related]  

  • 17. Dual inhibitors of cyclooxygenase and 5-lipoxygenase. A new avenue in anti-inflammatory therapy?
    Fiorucci S; Meli R; Bucci M; Cirino G
    Biochem Pharmacol; 2001 Dec; 62(11):1433-8. PubMed ID: 11728379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic and pharmacodynamic aspects of the ideal COX-2 inhibitor: a pharmacologist's perspective.
    Brune K; Neubert A
    Clin Exp Rheumatol; 2001; 19(6 Suppl 25):S51-7. PubMed ID: 11695253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo pharmacological evidence of selective cyclooxygenase-2 inhibition by nimesulide: an overview.
    Famaey JP
    Inflamm Res; 1997 Nov; 46(11):437-46. PubMed ID: 9427063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of aspirin in the long-term management of atherothrombosis.
    Patrono C
    Haematologica; 2002 Jan; 87(1):6-8. PubMed ID: 11801459
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 52.